Mettler-Toledo enters the second half as a precision-measurement franchise whose second-quarter print finally showed the China and service flywheel restarting after a tariff-heavy year. The company is not a conglomerate life-sciences platform. It is a focused oligopolist in laboratory balances, industrial weighing, process analytics, and end-of-line inspection, converting a mid-single-digit top line into double-digit earnings growth through price, mix, and a relentless buyback. The investment debate is whether that conversion still deserves a quality-compounder multiple now that China has reaccelerated and management has already banked the beat in a modest guidance raise.
Organic sales grew 4%. That figure excludes acquisitions and a one-time customer tariff refund. China grew 9%, led by industrial demand in batteries and new energy. The Americas barely advanced. Service grew 7% organically and is approaching a billion-dollar run rate. That mix shift protects the margin story when product cycles wobble. Adjusted earnings rose 14%. The full-year raise simply captured the second-quarter beat rather than implying a hotter second half.
The shares trade near $1,392. That is about 27 times next-year earnings. Enterprise value sits in the mid-twenties on trailing EBITDA. Free cash flow guidance near $900 million funds a large repurchase plan. The balance sheet still carries thin cash and almost no book equity. The question the next two quarters resolve is whether China stays in the high single digits and the Americas stop being a drag. Second-half guidance itself still treats the recovery as mid-single-digit and cautious.